Christine R Larson - Net Worth and Insider Trading
Christine R Larson Net Worth
The estimated net worth of Christine R Larson is at least $108,060 dollars as of 2024-04-23. Christine R Larson is the Vice President and CFO of PDL BioPharma Inc and owns about 43,749 shares of PDL BioPharma Inc (PDLI) stock worth over $108,060. Details can be seen in Christine R Larson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Christine R Larson has not made any transactions after 2010-05-14 and currently still holds the listed stock(s).
Transaction Summary of Christine R Larson
Christine R Larson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christine R Larson owns 2 companies in total, including Dynavax Technologies Corp (DVAX) , and PDL BioPharma Inc (PDLI) .
Click here to see the complete history of Christine R Larson’s form 4 insider trades.
Insider Ownership Summary of Christine R Larson
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
DVAX | Dynavax Technologies Corp | 2012-08-13 | VP and Chief Financial Officer |
PDLI | PDL BioPharma Inc | 2011-05-23 | Vice President and CFO |
Christine R Larson Latest Holdings Summary
Christine R Larson currently owns a total of 1 stock. Christine R Larson owns 43,749 shares of PDL BioPharma Inc (PDLI) as of May 14, 2010, with a value of $108,060.
Latest Holdings of Christine R Larson
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
PDLI | PDL BioPharma Inc | 2010-05-14 | 43,749 | 2.47 | 108,060 |
Holding Weightings of Christine R Larson
Christine R Larson Form 4 Trading Tracker
According to the SEC Form 4 filings, Christine R Larson has made a total of 0 transactions in PDL BioPharma Inc (PDLI) over the past 5 years. The most-recent trade in PDL BioPharma Inc is the acquisition of 5,000 shares on May 14, 2010, which cost Christine R Larson around $28,550.
Insider Trading History of Christine R Larson
- 1
Christine R Larson Trading Performance
GuruFocus tracks the stock performance after each of Christine R Larson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christine R Larson is -1.51%. GuruFocus also compares Christine R Larson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christine R Larson within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Christine R Larson's insider trading performs compared to the benchmark.
Performance of Christine R Larson
Average Return
10.46%
Outperforming Transactions
100%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | -7.09 | -1.51 | -7.86 | 10.46 | 5.09 | 11.26 |
Relative Return to S&P 500(%) | -0.96 | 4.57 | -10.51 | -5.89 | -3.44 | -0.57 |
Christine R Larson Ownership Network
Ownership Network List of Christine R Larson
Ownership Network Relation of Christine R Larson
Christine R Larson Owned Company Details
What does Dynavax Technologies Corp do?
Who are the key executives at Dynavax Technologies Corp?
Christine R Larson is the VP and Chief Financial Officer of Dynavax Technologies Corp. Other key executives at Dynavax Technologies Corp include Principal Accounting Officer Justin Burgess , Chief Medical Officer and VP Robert Janssen , and Senior Vice President David F Novack .
Dynavax Technologies Corp (DVAX) Insider Trades Summary
Over the past 18 months, Christine R Larson made no insider transaction in Dynavax Technologies Corp (DVAX). Other recent insider transactions involving Dynavax Technologies Corp (DVAX) include a net sale of 238,719 shares made by David F Novack , a net sale of 46,327 shares made by Robert Janssen , and a net sale of 4,500,000 shares made by Hack Andrew A. F. .
In summary, during the past 3 months, insiders sold 20,526 shares of Dynavax Technologies Corp (DVAX) in total and bought 0 shares, with a net sale of 20,526 shares. During the past 18 months, 4,836,004 shares of Dynavax Technologies Corp (DVAX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,836,004 shares.
Dynavax Technologies Corp (DVAX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Dynavax Technologies Corp Insider Transactions
Christine R Larson Mailing Address
Above is the net worth, insider trading, and ownership report for Christine R Larson. You might contact Christine R Larson via mailing address: C/o Pdl Biopharma, 932 Southwood Boulevard, Incline Village Nv 89451.